How personalized vaccines combat cancer | Tomorrow's Cure Episode 5

Research scientists are equipping a vaccine with bits of proteins that redirect the immune system's efforts to specifically fight cancer. The vaccine aims to prevent ovarian cancer tumors from returning, as relapsing cancer is often more aggressive and difficult to treat. The latest research also seeks to understand why some ovarian cancer tumors evade the body's immune response. Featured experts are Dr. Keith Knutson, Immunologist and Cancer Vaccine Researcher at Mayo Clinic; Dr. Saranya Chumsri, Hematologist at Mayo Clinic​; and Dr. Nora Disis, Director of the Institute of Translational Health Science and the Center for Translational Medicine in Women’s Health at University of Washington.
Subscribe to Tomorrow's Cure wherever you get your podcasts. Visit www.tomorrowsc... for more information.
From Mayo Clinic to your inbox, sign-up for free: mayocl.in/3e71zfi
Visit Mayo Clinic: www.mayoclinic...
Like Mayo Clinic on Facebook: / mayoclinic
Follow Mayo Clinic on Instagram: / mayoclinic
Follow Mayo Clinic on X, formerly Twitter: x.com/MayoClinic
Follow Mayo Clinic on Threads: www.threads.ne...
This podcast is for informational purposes only and should not be relied upon as professional, medical or legal advice. Always consult with a qualified health care provider for any medical advice. The appearance of any guest does not imply an endorsement of them, their employer, or any entity they represent. The views and opinions are those of the speakers and do not necessarily reflect the views of Mayo Clinic. Reference to any product, service or entity does not constitute an endorsement or recommendation by Mayo Clinic.